Find out what’s happening at Pivot Park. Stay informed on the latest collaborations, scientific breakthroughs and developments in drug discovery and life sciences. Explore how innovators at the park are shaping the future of health, technology and entrepreneurship.
Delegation from Baden-Württemberg visits Pivot Park
On Tuesday 4 June, Pivot Park had the honour of welcoming a business delegation from Baden-Württemberg, a region in southern Germany. The visit was part of a two-day mission to the Netherlands, particularly to in Noord-Brabant, centred around the theme “Personalised Medicine: Tailor-made Solutions through Life Sciences and Diagnostics.”
Pivot Park and QuestPair: Smart labs, strong starts
Throughout 2024, the Pivot Incubator team worked hard to ensure that the laboratories were fully equipped, allowing future startups to begin immediately. We recognised that setting up a well-equipped lab can be a significant challenge for emerging businesses, which is why we prioritised providing turnkey facilities. To achieve this, we partnered with expert organisations such as QuestPair.
Supporting talent through the Pedro Hermkens stipend
At Pivot Park, we believe in empowering the people behind innovation. Through the Pedro Hermkens stipend, we support employees of campus-based companies in pursuing professional development.
The annual €1,000 stipend enables them to follow advanced courses or training to boost their skills and careers. Last year’s recipient, Josephine Stein (Citryll), completed a 10-week Harvard course in immunology.
Marie Curie Building Crowned the Most Beautiful Building in Oss by jury
The Marie Curie Building at Pivot Park has been awarded the jury prize for the Most Beautiful Building in Oss, as announced during the prestigious ceremony held on Wednesday, 15 January. The expert jury highlighted the building’s strength through simplicity in design, achieving high-quality architecture with minimal means.
STANT: New Biotech Company at Pivot Park
STANT, a new Dutch company based at the Pivot Park in Oss, is developing proprietary inhibitors of the STING pathway with a unique and differentiated mechanism of action.
Dennis Löwik: New lector Drug Discovery at Pivot Park
Dennis Löwik is the new Drug Discovery lecturer at Pivot Park, aiming to boost research with AI and foster industry collaborations. He aims to expand the lectureship in terms of people and research in the coming years.
Pivot park proud sponsor of the PhD Competition at FIGON Dutch Medicine Days
This past Wednesday and Thursday, the Figon Dutch Medicine Days took place, where we were proud to sponsor the PhD Award. This initiative provides talented PhD candidates from different regions with the opportunity to present their innovative research.
Minister of Health, Pia Dijkstra, visited Pivot Park
On 15 May 2024, we had the pleasure of a visit from our Minister of Health, Pia Dijkstra. We provided insights into our operations, and afterwards, we discussed strategies for tackling and preventing medicine shortages in the future.
Unveiling Pivot Park’s new Business Hub
Discover Pivot Park’s new Business Hub, uniting 14 companies in the campus center. Empowering biopharmaceutical startups and scale-ups for collaborative innovation in pioneering R&D. Join us at the forefront of advancing medicine.
Introducing the Pedro Hermkens Stipend: Empowering professional growth at Pivot Park
At Pivot Park, we recognize the importance of investing in the ongoing development of our community members. The Pedro Hermkens Stipend offers our community a maximum award of 1,000 euros, providing vital support for their career endeavours.
Following almost two years of construction, the Curie building at Pivot Park is nearly ready to welcome its first tenants. This compact 9-storey building, offering plenty of light and easy adaptation to tenants’ needs, is designed based on collaboration, with a central meeting hub and office spaces, customised laboratories, and communal facilities.
Press release: Pivot Park grows by over 25% with the completion of the Grizzly project
Today, contractor Dura Vermeer Bouw Zuid completes the Grizzly project after nearly 2 years of construction, delivering it to Pivot Park. The 9-story building, named after Nobel laureate Marie Curie, will house offices, laboratories, and shared facilities. With the completion of this sustainable building, Pivot Park adds 11,000 square meters to its successful campus, marking an expansion of over 25 percent.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.